Cite
HARVARD Citation
Rodier, C. et al. (2023). Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab. HemaSphere. 7 (5), pp. e861-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rodier, C. et al. (2023). Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab. HemaSphere. 7 (5), pp. e861-. [Online].